For: | Kucera O, Cervinkova Z. Experimental models of non-alcoholic fatty liver disease in rats. World J Gastroenterol 2014; 20(26): 8364-8376 [PMID: 25024595 DOI: 10.3748/wjg.v20.i26.8364] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i26/8364.htm |
Number | Citing Articles |
1 |
Clarissa Berardo, Laura Giuseppina Di Pasqua, Marta Cagna, Plinio Richelmi, Mariapia Vairetti, Andrea Ferrigno. Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research. International Journal of Molecular Sciences 2020; 21(24): 9646 doi: 10.3390/ijms21249646
|
2 |
Z Ehsanifard, F Mir Mohammadrezaei, M Ghobad-Nejhad, AR Safarzade. The Effect of Aqueous Extract of Inocutis levis on Liver Histopathology and Hypertriglyceridemia in High Sucrose-fed Wistar Rats. Journal of Medicinal Plants 2019; 2(70): 181 doi: 10.29252/jmp.2.70.181
|
3 |
Alana Aragón-Herrera, Manuel Otero-Santiago, Laura Anido-Varela, Sandra Moraña-Fernández, Manuel Campos-Toimil, Tomás García-Caballero, Luis Barral, Estefanía Tarazón, Esther Roselló-Lletí, Manuel Portolés, Oreste Gualillo, Isabel Moscoso, Ricardo Lage, José Ramón González-Juanatey, Sandra Feijóo-Bandín, Francisca Lago. The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.827033
|
4 |
P. Königshofer, K. Brusilovskaya, P. Schwabl, T. Reiberger. Animal models of portal hypertension. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019; 1865(5): 1019 doi: 10.1016/j.bbadis.2018.07.018
|
5 |
Leslye Sámano-Hernández, Reyna Fierro, Aude Marchal, Jean-Louis Guéant, Humberto González-Márquez, Rosa-María Guéant-Rodríguez. Beneficial and deleterious effects of sitagliptin on a methionine/choline-deficient diet-induced steatohepatitis in rats. Biochimie 2021; 181: 240 doi: 10.1016/j.biochi.2020.12.004
|
6 |
Yongqing Zhou, Chuanchen Wu, Xin Wang, Ping Li, Nannan Fan, Wei Zhang, Zhenzhen Liu, Wen Zhang, Bo Tang. Exploring the Changes of Peroxisomal Polarity in the Liver of Mice with Nonalcoholic Fatty Liver Disease. Analytical Chemistry 2021; 93(27): 9609 doi: 10.1021/acs.analchem.1c01776
|
7 |
Yingying Yan, Wenhui Zhang. Potentilla anserina L. attenuates oleic acid-induced steatosis in HepG2 cells and hyperlipidemia in high fat diet-induced obese mice. Journal of Functional Foods 2023; 109: 105772 doi: 10.1016/j.jff.2023.105772
|
8 |
A study on hepatopathic, dyslipidemic and immunogenic properties of fructosylated-HSA-AGE and binding of autoantibodies in sera of obese and overweight patients with fructosylated-HSA-AGE. PLOS ONE 2019; 14(5): e0216736 doi: 10.1371/journal.pone.0216736
|
9 |
Branka Šošić-Jurjević, Dieter Lütjohann, Svetlana Trifunović, Slađan Pavlović, Slavica Borković Mitić, Ljubiša Jovanović, Nataša Ristić, Ljiljana Marina, Vladimir Ajdžanović, Branko Filipović. Differences in Cholesterol Metabolism, Hepato-Intestinal Aging, and Hepatic Endocrine Milieu in Rats as Affected by the Sex and Age. International Journal of Molecular Sciences 2023; 24(16): 12624 doi: 10.3390/ijms241612624
|
10 |
Sihyang Jo, Jin-Mo Kim, Minshu Li, Han Sun Kim, Yong Jin An, Sunghyouk Park. TAT as a new marker and its use for noninvasive chemical biopsy in NASH diagnosis. Molecular Medicine 2024; 30(1) doi: 10.1186/s10020-024-00992-8
|
11 |
JianHua Han, Anika L. Dzierlenga, Zhengqiang Lu, Dean D. Billheimer, Elmira Torabzadeh, April D. Lake, Hui Li, Petr Novak, Petia Shipkova, Nelly Aranibar, Donald Robertson, Michael D. Reily, Lois D. Lehman‐McKeeman, Nathan J. Cherrington. Metabolomic profiling distinction of human nonalcoholic fatty liver disease progression from a common rat model. Obesity 2017; 25(6): 1069 doi: 10.1002/oby.21855
|
12 |
Garyfallia Kapravelou, Rosario Martínez, Ana M. Andrade, Elena Nebot, Daniel Camiletti-Moirón, Virginia A. Aparicio, Maria Lopez-Jurado, Pilar Aranda, Francisco Arrebola, Eduardo Fernandez-Segura, Giovanna Bermano, Marie Goua, Milagros Galisteo, Jesus M. Porres. Aerobic interval exercise improves parameters of nonalcoholic fatty liver disease (NAFLD) and other alterations of metabolic syndrome in obese Zucker rats. Applied Physiology, Nutrition, and Metabolism 2015; 40(12): 1242 doi: 10.1139/apnm-2015-0141
|
13 |
Ides M. Colin, Henri Colin, Ines Dufour, Charles‐Edouard Gielen, Marie‐Christine Many, Jean Saey, Bernard Knoops, Anne‐Catherine Gérard. Extrapancreatic effects of incretin hormones: evidence for weight‐independent changes in morphological aspects and oxidative status in insulin‐sensitive organs of the obese nondiabetic Zucker rat (ZFR). Physiological Reports 2016; 4(15) doi: 10.14814/phy2.12886
|
14 |
Samira Faraji, Mohammad Reza Mohammad Hosseini Azar, Mohammad Alizadeh. Brewed chicory leaf consumption has unexpected side effects along beneficial effects on liver enzymes in non-alcoholic fatty liver disease patients. Journal of Herbal Medicine 2022; 34: 100572 doi: 10.1016/j.hermed.2022.100572
|
15 |
Emilio Herrera, Encarnación Amusquivar. Dietary Interventions in Liver Disease. 2019; : 287 doi: 10.1016/B978-0-12-814466-4.00024-0
|
16 |
Ying Zhang, Danni Xiang, Xiaona Hu, Qingwei Ruan, Lina Wang, Zhijun Bao. Identification and study of differentially expressed miRNAs in aged NAFLD rats based on high-throughput sequencing. Annals of Hepatology 2020; 19(3): 302 doi: 10.1016/j.aohep.2019.12.003
|
17 |
Yvonne Oligschlaeger, Ronit Shiri-Sverdlov. NAFLD Preclinical Models: More than a Handful, Less of a Concern?. Biomedicines 2020; 8(2): 28 doi: 10.3390/biomedicines8020028
|
18 |
Samuel J. Daniels, Diana J. Leeming, Sönke Detlefsen, Maria F. Bruun, Sara T. Hjuler, Kim Henriksen, Peter Hein, Morten A. Karsdal, Sarah Brockbank, Simon Cruwys. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis – Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue. Biomedicine & Pharmacotherapy 2019; 111: 926 doi: 10.1016/j.biopha.2018.12.130
|
19 |
Catherine M. Pastor, Valérie Vilgrain. Steatosis Alters the Activity of Hepatocyte Membrane Transporters in Obese Rats. Cells 2021; 10(10): 2733 doi: 10.3390/cells10102733
|
20 |
Elena Grasselli, Laura Canesi, Piero Portincasa, Adriana Voci, Laura Vergani, Ilaria Demori. Models of non-Alcoholic Fatty Liver Disease and Potential Translational Value: the Effects of 3,5-L-diiodothyronine. Annals of Hepatology 2017; 16(5): 707 doi: 10.5604/01.3001.0010.2713
|
21 |
Svetlana Rodimova, Vadim Elagin, Maria Karabut, Irina Koryakina, Alexander Timin, Vladimir Zagainov, Mikhail Zyuzin, Elena Zagaynova, Daria Kuznetsova. Toxicological Analysis of Hepatocytes Using FLIM Technique: In Vitro versus Ex Vivo Models. Cells 2021; 10(11): 2894 doi: 10.3390/cells10112894
|
22 |
Ana I. Álvarez‐Mercado, José Gulfo, Manuel Romero Gómez, Mónica B. Jiménez‐Castro, Jordi Gracia‐Sancho, Carmen Peralta. Use of Steatotic Grafts in Liver Transplantation: Current Status. Liver Transplantation 2019; 25(5): 771 doi: 10.1002/lt.25430
|
23 |
Rosario Martínez, Garyfallia Kapravelou, Ana Donaire, Carlos Lopez-Chaves, Francisco Arrebola, Milagros Galisteo, Samuel Cantarero, Pilar Aranda, Jesus M. Porres, María López-Jurado. Effects of a combined intervention with a lentil protein hydrolysate and a mixed training protocol on the lipid metabolism and hepatic markers of NAFLD in Zucker rats. Food & Function 2018; 9(2): 830 doi: 10.1039/C7FO01790A
|
24 |
Manoj K. Singh, Rohit Yadav, Akash Kumar Bhaskar, Shantanu Sengupta, Chetana Sachidanandan. A diet-independent zebrafish model for NAFLD recapitulates patient lipid profiles and offers a system for small molecule screening. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2023; 1868(1): 159246 doi: 10.1016/j.bbalip.2022.159246
|
25 |
Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli, Amedeo Lonardo. The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans. Advances in Therapy 2016; 33(3): 291 doi: 10.1007/s12325-016-0306-9
|
26 |
Theodore Karatzas, Nikolaos Sikalias, Dimitrios Mantas, Apostolos Papalois, Konstantinos Alexiou, Lamprini Mountzalia, Gregory Kouraklis. Histopathological changes and onset of severe hepatic steatosis in rats fed a choline‑free diet. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6385
|
27 |
Syifa Mustika, Dewi Santosaningsih, Dian Handayani, Achmad Rudijanto. Impact of multiple different high-fat diets on metabolism, inflammatory markers, dysbiosis, and liver histology: study on NASH rat model induced diet. F1000Research 2023; 12: 180 doi: 10.12688/f1000research.129645.1
|
28 |
Miguel Vázquez-Velasco, Laura González-Torres, Rosa A. García-Fernández, María Teresa Méndez, Sara Bastida, Juana Benedí, María José González-Muñoz, Francisco J. Sánchez-Muniz. Glucomannan or Glucomannan Plus Spirulina-Enriched Squid-Surimi Diets Reduce Histological Damage to Liver and Heart in Zucker fa/fa Rats Fed a Cholesterol-Enriched and Non-Cholesterol-Enriched Atherogenic Diet. Journal of Medicinal Food 2017; 20(6): 618 doi: 10.1089/jmf.2016.0157
|
29 |
Dominika Stygar, Tomasz Sawczyn, Agnieszka Dulska, Elżbieta Chełmecka, Łukasz Mielańczyk, Natalia Matysiak, Michał Kukla, Maciej Idzik, Jan Augustyniak, Andrzej Gabriel, Konrad Karcz, Jerzy Jochem. Ileal transposition helps to regulate plasma hepatokine levels in obese Zucker (Crl:ZUC(ORL)-Leprfa) rats. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-87293-w
|
30 |
Andrea Ferrigno, Marta Cagna, Oriana Bosco, Michelangelo Trucchi, Clarissa Berardo, Ferdinando Nicoletti, Mariapia Vairetti, Laura G. Di Pasqua. MPEP Attenuates Intrahepatic Fat Accumulation in Obese Mice. International Journal of Molecular Sciences 2023; 24(7): 6076 doi: 10.3390/ijms24076076
|
31 |
Vignan Manne, Priya Handa, Kris V. Kowdley. Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. Clinics in Liver Disease 2018; 22(1): 23 doi: 10.1016/j.cld.2017.08.007
|
32 |
Hassan Reda Hassan Elsayed, Mohammad El-Nablaway, Basma Adel Khattab, Rania N. Sherif, Wagdi Fawzy Elkashef, Asim Mohammed Abdalla, Eman Mohammad El Nashar, Mostafa Mohammed Abd-Elmonem, Randa El-Gamal. Independent of Calorie Intake, Short-term Alternate-day Fasting Alleviates NASH, With Modulation of Markers of Lipogenesis, Autophagy, Apoptosis, and Inflammation in Rats. Journal of Histochemistry & Cytochemistry 2021; 69(9): 575 doi: 10.1369/00221554211041607
|
33 |
Peter M. Meggyesy, Shashank Masaldan, Sharnel A. S. Clatworthy, Irene Volitakis, Daniel J. Eyckens, Kathryn Aston-Mourney, Michael A. Cater. Copper Ionophores as Novel Antiobesity Therapeutics. Molecules 2020; 25(21): 4957 doi: 10.3390/molecules25214957
|
34 |
Donald B Jump, Christopher M Depner, Sasmita Tripathy, Kelli A Lytle. Potential for Dietary ω-3 Fatty Acids to Prevent Nonalcoholic Fatty Liver Disease and Reduce the Risk of Primary Liver Cancer. Advances in Nutrition 2015; 6(6): 694 doi: 10.3945/an.115.009423
|
35 |
Leyli Zahra Bahreini Boroujeni, Mohammad Mehdi Haghighat_Lari, Abolfazl Ghandi, Seyed Mahmood Hashemian, Rana Shafabakhsh, Zarrin Banikazemi, Mohsen Taghizadeh. Effects of black mulberry leaf extract on liver health and metabolic parameters in rats with high-fat diet-induced liver changes. Obesity Medicine 2024; 50: 100554 doi: 10.1016/j.obmed.2024.100554
|
36 |
Samuel J. Daniels, Diana J. Leeming, Sönke Detlefsen, Maria F. Bruun, Sara T. Hjuler, Kim Henriksen, Peter Hein, Aleksander Krag, Morten A. Karsdal, Mette Juul Nielsen, Sarah Brockbank, Simon Cruwys. Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(3): G410 doi: 10.1152/ajpgi.00066.2019
|
37 |
Pablo Muriel, Pedro López-Sánchez, Erika Ramos-Tovar. Fructose and the Liver. International Journal of Molecular Sciences 2021; 22(13): 6969 doi: 10.3390/ijms22136969
|
38 |
Avishek Mandal. Cattle Diseases - Molecular and Biochemical Approach. Veterinary Medicine and Science 2023; 16 doi: 10.5772/intechopen.108151
|
39 |
Bayan Abdulhafid Aljahdali, Adnan Salem Bajaber, Doha M. Al-Nouri, Abdulrahman Saleh Al-Khalifah, Shaista Arzoo, Abeer Abdullah Alasmari. The Development of Nonalcoholic Fatty Liver Disease and Metabolic Syndromes in Diet-Induced Rodent Models. Life 2023; 13(6): 1336 doi: 10.3390/life13061336
|
40 |
Ides M. Colin, Bernard Knoops, Anne-Catherine Gérard. Incretin-induced changes in the transcriptome of skeletal muscles of fa/fa Zucker rat (ZFR) with obesity, without diabetes. International Journal of Obesity 2022; 46(7): 1311 doi: 10.1038/s41366-022-01114-2
|
41 |
W Shan, L Gao, W Zeng, Y Hu, G Wang, M Li, J Zhou, X Ma, X Tian, J Yao. Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease. Cell Death & Disease 2015; 6(7): e1833 doi: 10.1038/cddis.2015.196
|
42 |
Giuseppina Palladini, Andrea Ferrigno, Laura Giuseppina Di Pasqua, Clarissa Berardo, Vittoria Rizzo, Stefano Perlini, Mariapia Vairetti, Chen Ling. Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease. PLOS ONE 2020; 15(12): e0243179 doi: 10.1371/journal.pone.0243179
|
43 |
Naruemon Klaikeaw, Jutamas Wongphoom, Duangporn Werawatganon, Maneerat Chayanupatkul, Prasong Siriviriyakul. Anti-inflammatory and anti-oxidant effects of aloe vera in rats with non-alcoholic steatohepatitis. World Journal of Hepatology 2020; 12(7): 363-377 doi: 10.4254/wjh.v12.i7.363
|
44 |
Hong Xu, Yang Zhou, Yongxia Liu, Jian Ping, Qiyang Shou, Fangming Chen, Ru Ruo. Metformin improves hepatic IRS2/PI3K/Akt signaling in insulin-resistant rats of NASH and cirrhosis. Journal of Endocrinology 2016; 229(2): 133 doi: 10.1530/JOE-15-0409
|
45 |
Kiminori Watanabe, Masayuki Ohta, Hiroomi Takayama, Kazuhiro Tada, Yuki Shitomi, Takahide Kawasaki, Yuichiro Kawano, Yuichi Endo, Yukio Iwashita, Masafumi Inomata. Effects of Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease in an Obese Rat Model. Obesity Surgery 2018; 28(6): 1532 doi: 10.1007/s11695-017-3052-4
|
46 |
Jennifer Berumen, Jacopo Baglieri, Tatiana Kisseleva, Kristin Mekeel. Liver fibrosis: Pathophysiology and clinical implications. WIREs Mechanisms of Disease 2021; 13(1) doi: 10.1002/wsbm.1499
|
47 |
Rownock Afruza, Nikhil V. Dhurandhar, Vijay Hegde. E4orf1 Prevents Progression of Fatty Liver Disease in Mice on High Fat Diet. International Journal of Molecular Sciences 2022; 23(16): 9286 doi: 10.3390/ijms23169286
|
48 |
Anna C. Croce, Andrea Ferrigno, Laura G. Di Pasqua, Clarissa Berardo, Valeria Maria Piccolini, Vittorio Bertone, Giovanni Bottiroli, Mariapia Vairetti. Autofluorescence discrimination of metabolic fingerprint in nutritional and genetic fatty liver models. Journal of Photochemistry and Photobiology B: Biology 2016; 164: 13 doi: 10.1016/j.jphotobiol.2016.09.015
|
49 |
Mohammed Abdo Yahya, Ghedeir M. Alshammari, Magdi A. Osman, Laila Naif Al-Harbi, Abu ElGasim A. Yagoub, Sahar Abdulaziz AlSedairy. Liquorice root extract and isoliquiritigenin attenuate high-fat diet-induced hepatic steatosis and damage in rats by regulating AMPK. Archives of Physiology and Biochemistry 2024; 130(4): 385 doi: 10.1080/13813455.2022.2102654
|
50 |
Eduardo E. Vargas-Pozada, Erika Ramos-Tovar, Consuelo Acero-Hernández, Irina Cardoso-Lezama, Silvia Galindo-Gómez, Víctor Tsutsumi, Pablo Muriel. Caffeine mitigates experimental nonalcoholic steatohepatitis and the progression of thioacetamide-induced liver fibrosis by blocking the MAPK and TGF-β/Smad3 signaling pathways. Annals of Hepatology 2022; 27(2): 100671 doi: 10.1016/j.aohep.2022.100671
|
51 |
Wei-ning Jiang, Dan Li, Tao Jiang, Jiao Guo, Yan-fen Chen, Jie Wang, Yun Zhou, Chao-yan Yang, Chun-ping Tang. Protective Effects of Chaihu Shugan San (柴胡疏肝散) on Nonalcoholic Fatty Liver Disease in Rats with Insulin Resistance. Chinese Journal of Integrative Medicine 2018; 24(2): 125 doi: 10.1007/s11655-016-2252-4
|
52 |
Sung-woon Park, Yoon-jeong Seo, Hyun-jeong Choi, Jae-hwan Lew. Dyslipidemic Effect of Pravastatin and Herbal Medicine in Rats. The Journal of Internal Korean Medicine 2017; 38(3): 327 doi: 10.22246/jikm.2017.38.3.327
|
53 |
Davood Dorranipour, Fahimeh Pourjafari, Reza Malekpour-Afshar, Mohsen Basiri, Mehran Hosseini. RETRACTED: Astrocyte response to melatonin treatment in rats under high-carbohydrate high-fat diet. Journal of Chemical Neuroanatomy 2024; 136: 102389 doi: 10.1016/j.jchemneu.2024.102389
|
54 |
Sara G. Higarza, Silvia Arboleya, Miguel Gueimonde, Eneritz Gómez-Lázaro, Jorge L. Arias, Natalia Arias, Florian Reichmann. Neurobehavioral dysfunction in non-alcoholic steatohepatitis is associated with hyperammonemia, gut dysbiosis, and metabolic and functional brain regional deficits. PLOS ONE 2019; 14(9): e0223019 doi: 10.1371/journal.pone.0223019
|
55 |
Dian Handayani, Erlinda Febrianingsih, Adelya Desi Kurniawati, Inggita Kusumastuty, Shafira Nurmalitasari, Rahma Micho Widyanto, Diah Novida Oktaviani, Alma Maghfirotun Innayah, Etik Sulistyowati. High-Fructose Diet Initially Promotes Increased Aortic Wall Thickness, Liver Steatosis, and Cardiac Histopathology Deterioration, but Does Not Increase Body Fat Index. Journal of Public Health Research 2021; 10(2) doi: 10.4081/jphr.2021.2181
|
56 |
Isabel Freitas, Eleonora Boncompagni, Eleonora Tarantola, Cristian Gruppi, Vittorio Bertone, Andrea Ferrigno, Gloria Milanesi, Rita Vaccarone, M. Enrica Tira, Mariapia Vairetti, Francisco Javier Romero. In Situ Evaluation of Oxidative Stress in Rat Fatty Liver Induced by a Methionine‐ and Choline‐Deficient Diet. Oxidative Medicine and Cellular Longevity 2016; 2016(1) doi: 10.1155/2016/9307064
|
57 |
Silvia Carvajal, Meritxell Perramón, Denise Oró, Eudald Casals, Guillermo Fernández-Varo, Gregori Casals, Marina Parra, Bernardino González de la Presa, Jordi Ribera, Óscar Pastor, Manuel Morales-Ruíz, Víctor Puntes, Wladimiro Jiménez. Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-49262-2
|
58 |
Erenius Toppo, S. Sylvester Darvin, S. Esakkimuthu, K. Buvanesvaragurunathan, T.P. Ajeesh Krishna, S. Antony Caesar, A. Stalin, K. Balakrishna, P. Pandikumar, S. Ignacimuthu, N.A. Al-Dhabi. Curative effect of arjunolic acid from Terminalia arjuna in non-alcoholic fatty liver disease models. Biomedicine & Pharmacotherapy 2018; 107: 979 doi: 10.1016/j.biopha.2018.08.019
|
59 |
Alejandro Soto-Gutierrez, Albert Gough, Lawrence A Vernetti, DL Taylor, Satdarshan P Monga. Pre-clinical and clinical investigations of metabolic zonation in liver diseases: The potential of microphysiology systems. Experimental Biology and Medicine 2017; 242(16): 1605 doi: 10.1177/1535370217707731
|
60 |
Davood Dorranipour, Fahimeh Pourjafari, Reza Malekpour-Afshar, Mohsen Basiri, Mehran Hosseini. Assessment of melatonin’s therapeutic effectiveness against hepatic steatosis induced by a high-carbohydrate high-fat diet in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(5): 2971 doi: 10.1007/s00210-023-02784-z
|
61 |
Antonio Carlos Soares Pantaleão, Marcio Pinto de Castro, Krishynan Shanty Fernandes Meirelles Araujo, Carlos Frederico Ferreira Campos, André Luiz Alves da Silva, José Eduardo Ferreira Manso, João Carlos Machado. Ultrasound biomicroscopy for the assessment of early-stage nonalcoholic fatty liver disease induced in rats by a high-fat diet. Ultrasonography 2022; 41(4): 750 doi: 10.14366/usg.21182
|
62 |
Weijia Yang, Minchun Yang, Hui Yao, Yelin Ma, Xuanxuan Ren, Long Teng, Tao Wang. Protective role of arnebin-1 in rats with nonalcoholic fatty liver disease. Journal of International Medical Research 2019; 47(3): 1250 doi: 10.1177/0300060518813058
|
63 |
Jill L Sherriff, Therese A O'Sullivan, Catherine Properzi, Josephine-Lee Oddo, Leon A Adams. Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes. Advances in Nutrition 2016; 7(1): 5 doi: 10.3945/an.114.007955
|
64 |
Fei Xiong, Zhongdaixi Zheng, Lingyu Xiao, Chuhong Su, Junbin Chen, Xiangfu Gu, Jiaqi Tang, Yue Zhao, Huiyu Luo, Longying Zha. Soyasaponin A2 Alleviates Steatohepatitis Possibly through Regulating Bile Acids and Gut Microbiota in the Methionine and Choline‐Deficient (MCD) Diet‐induced Nonalcoholic Steatohepatitis (NASH) Mice. Molecular Nutrition & Food Research 2021; 65(14) doi: 10.1002/mnfr.202100067
|
65 |
Joana Fisch, Vanessa Feistauer, Ana Carolina de Moura, Andrew Oliveira Silva, Vanessa Bollis, Marilene Porawski, Silvana Almeida, Renata Padilha Guedes, Alethea Gatto Barschak, Márcia Giovenardi. Maternal feeding associated to post-weaning diet affects metabolic and behavioral parameters in female offspring. Physiology & Behavior 2019; 204: 162 doi: 10.1016/j.physbeh.2019.02.026
|
66 |
Edmund B. Chen, Cori Cason, Jack A. Gilbert, Karen J. Ho. Current State of Knowledge on Implications of Gut Microbiome for Surgical Conditions. Journal of Gastrointestinal Surgery 2018; 22(6): 1112 doi: 10.1007/s11605-018-3755-4
|
67 |
Chu-wen Lin, Xiao-li Huang, Hai-lin Liu, Yan Wang. Interactions of Hepatitis B Virus Infection with Nonalcoholic Fatty Liver Disease: Possible Mechanisms and Clinical Impact. Digestive Diseases and Sciences 2015; 60(12): 3513 doi: 10.1007/s10620-015-3772-z
|
68 |
Scott A. Willis, Sundus Malaikah, Siôn Parry, Stephen Bawden, Gaël Ennequin, Jack A. Sargeant, Thomas Yates, David R. Webb, Melanie J. Davies, David J. Stensel, Guruprasad P. Aithal, James A. King. The effect of acute and chronic exercise on hepatic lipid composition. Scandinavian Journal of Medicine & Science in Sports 2023; 33(5): 550 doi: 10.1111/sms.14310
|
69 |
Sera Kim, Jihye Hong, Raok Jeon, Hyun-Sook Kim. Adzuki bean ameliorates hepatic lipogenesis and proinflammatory mediator expression in mice fed a high-cholesterol and high-fat diet to induce nonalcoholic fatty liver disease. Nutrition Research 2016; 36(1): 90 doi: 10.1016/j.nutres.2015.11.002
|
70 |
Camilo Rey-Bedon, Peony Banik, Aslihan Gokaltun, O. Hofheinz, Martin.L. Yarmush, M. Korkut Uygun, O. Berk Usta. CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug-drug interactions in the fatty liver. Biomedicine & Pharmacotherapy 2022; 146: 112377 doi: 10.1016/j.biopha.2021.112377
|
71 |
Sara Carbajo-Pescador, David Porras, María Victoria García-Mediavilla, Susana Martínez-Flórez, María Juarez-Fernández, María José Cuevas, José Luis Mauriz, Javier González-Gallego, Esther Nistal, Sonia Sánchez-Campos. Beneficial effects of exercise on gut microbiota functionality and barrier integrity, and gut-liver crosstalk in an in vivo model of early obesity and non-alcoholic fatty liver disease. Disease Models & Mechanisms 2019; 12(5) doi: 10.1242/dmm.039206
|
72 |
Charlotte J. Green, Camilla Pramfalk, Karl J. Morten, Leanne Hodson. From whole body to cellular models of hepatic triglyceride metabolism: man has got to know his limitations. American Journal of Physiology-Endocrinology and Metabolism 2015; 308(1): E1 doi: 10.1152/ajpendo.00192.2014
|
73 |
R C Bortolin, A R Vargas, J Gasparotto, P R Chaves, C E Schnorr, Kd B Martinello, A K Silveira, T K Rabelo, D P Gelain, J C F Moreira. A new animal diet based on human Western diet is a robust diet-induced obesity model: comparison to high-fat and cafeteria diets in term of metabolic and gut microbiota disruption. International Journal of Obesity 2018; 42(3): 525 doi: 10.1038/ijo.2017.225
|
74 |
Chattraya Ngamlerst, Arunwan Udomkasemsab, Ratchanee Kongkachuichai, Karunee Kwanbunjan, Chaowanee Chupeerach, Pattaneeya Prangthip. The potential of antioxidant-rich Maoberry (Antidesma bunius) extract on fat metabolism in liver tissues of rats fed a high-fat diet. BMC Complementary and Alternative Medicine 2019; 19(1) doi: 10.1186/s12906-019-2716-0
|
75 |
Eman D. Mohammed, Ashraf B. Abdel-Naim, Jin Kangpeng, Runqiu Jiang, Jifu Wei, Beicheng Sun. The mother relationship between insulin resistance and non-alcoholic steatohepatitis: Glucosinolates hydrolysis products as a promising insulin resistance-modulator and fatty liver-preventer. Life Sciences 2021; 264: 118615 doi: 10.1016/j.lfs.2020.118615
|
76 |
Hui Wang, Zhongju Xu, Qi Wang, Shi Shu. Danshao Shugan Granule therapy for non-alcoholic fatty liver disease. Lipids in Health and Disease 2022; 21(1) doi: 10.1186/s12944-022-01689-9
|
77 |
R. Sivaraj, S. Jaikumar, S. Sengottuvelu. Zingiberene attenuates high fat diet–induced non-alcoholic fatty liver disease through suppression of lipogenesis and oxidative stress in rats. Comparative Clinical Pathology 2022; 31(2): 201 doi: 10.1007/s00580-022-03321-9
|
78 |
Dina E. Al-Wakeel, Dalia H. El-Kashef, Manar A. Nader. Renoprotective effect of empagliflozin in cafeteria diet-induced insulin resistance in rats: Modulation of HMGB-1/TLR-4/NF-κB axis. Life Sciences 2022; 301: 120633 doi: 10.1016/j.lfs.2022.120633
|
79 |
Zaki Utama, Sri Raharjo, Agnes Murdiati, Andriati Ningrum, M.Z. Abidin, R. Shamsudin, P. Tongdeenok, S.T. Sobue, A. Young, A. Hoque. Palm Oils Consumption Modulates Serum SGPT and SGOT in Rats Fed a High-Fat Diet. BIO Web of Conferences 2023; 80: 04005 doi: 10.1051/bioconf/20238004005
|
80 |
Dureen Samandar Eweis, Fida Abed, Johnny Stiban. Carbon dioxide in carbonated beverages induces ghrelin release and increased food consumption in male rats: Implications on the onset of obesity. Obesity Research & Clinical Practice 2017; 11(5): 534 doi: 10.1016/j.orcp.2017.02.001
|
81 |
Zhiyuan Chen, Yaling Liu, Li Yang, Peng Liu, Yu Zhang, Xiangyang Wang. MiR-149 attenuates endoplasmic reticulum stress-induced inflammation and apoptosis in nonalcoholic fatty liver disease by negatively targeting ATF6 pathway. Immunology Letters 2020; 222: 40 doi: 10.1016/j.imlet.2020.03.003
|
82 |
N. Sikalias, Maria Terzopoulou, K. Alexiou, Lamprini Mountzalia, Pagona Kamparoudi, Argyro Zacharioudaki, A. Papalois, T. Karatzas. The Effect of 30-minute Ischemia on the Levels of IL6, TNFα, NO, Glutathione and Lactic Acid in the Hepatic Tissue of Rats with Hepatic Steatosis. Hellenic Journal of Surgery 2019; 91(2): 65 doi: 10.1007/s13126-019-0508-0
|
83 |
Zhiyu Wu. Non-alcoholic Fatty Liver Disease: Pathology, Disease Models and Therapies. Highlights in Science, Engineering and Technology 2023; 36: 347 doi: 10.54097/hset.v36i.5702
|
84 |
Araní Casillas-Ramírez, Marc Micó-Carnero, Alfredo Sánchez-González, Cristina Maroto-Serrat, Andrés Trostchansky, Carmen Peralta. NO–IL-6/10–IL-1β axis: a new pathway in steatotic and non-steatotic liver grafts from brain-dead donor rats. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1178909
|
85 |
Wenhui Yang, Yan He, Shijie Liu, Lulu Gan, Zhiguo Zhang, Jun Wang, Jie Liang, Yang Dong, Qing Wang, Zongliu Hou, Li Yang. Integrative transcriptomic analysis of NAFLD animal model reveals dysregulated genes and pathways in metabolism. Gene 2016; 595(1): 99 doi: 10.1016/j.gene.2016.09.047
|
86 |
Simon N Dankel, Bodil Bjørndal, Carine Lindquist, Mari L Grinna, Christine Renate Rossmann, Pavol Bohov, Ottar Nygård, Seth Hallström, Elin Strand, Rolf K Berge. Hepatic Energy Metabolism Underlying Differential Lipidomic Responses to High-Carbohydrate and High-Fat Diets in Male Wistar Rats. The Journal of Nutrition 2021; 151(9): 2610 doi: 10.1093/jn/nxab178
|
87 |
Sevtap Kılınç, Pelin Şahin, Zeynep Yığman, Ayşe Meltem Sevgili. Topiramate’s effects on normal and fatty liver. Drug and Chemical Toxicology 2024; 47(5): 729 doi: 10.1080/01480545.2023.2276083
|
88 |
Esraa M. Zakariaª, Rasha H. Abdel-Ghanyª, Atef S. Elgharbawyª, Amira Ebrahim Alsemehᵇ, Sami S. Metwallyª. A novel approach to repositioning memantine for metabolic syndrome-induced steatohepatitis: Modulation of hepatic autophagy, inflammation, and fibrosis. Life Sciences 2023; 319: 121509 doi: 10.1016/j.lfs.2023.121509
|
89 |
Janet A. Thompson, Kristine Krajnak, Richard A. Johnston, Michael L. Kashon, Walter McKinney, Jeffrey S. Fedan. High-fat western diet-consumption alters crystalline silica-induced serum adipokines, inflammatory cytokines and arterial blood flow in the F344 rat. Toxicology Reports 2022; 9: 12 doi: 10.1016/j.toxrep.2021.12.001
|
90 |
Ayumi Fukuda, Marin Sasao, Eri Asakawa, Sumire Narita, Mei Hisano, Kazuhito Suruga, Mayuko Ichimura, Koichi Tsuneyama, Kazunari Tanaka, Katsuhisa Omagari. Dietary fat, cholesterol, and cholic acid affect the histopathologic severity of nonalcoholic steatohepatitis in Sprague-Dawley rats. Pathology - Research and Practice 2019; 215(11): 152599 doi: 10.1016/j.prp.2019.152599
|
91 |
Qing-Song Zhang, Feng-Wei Tian, Jian-Xin Zhao, Hao Zhang, Qi-Xiao Zhai, Wei Chen. The influence of dietary patterns on gut microbiome and its consequences for nonalcoholic fatty liver disease. Trends in Food Science & Technology 2020; 96: 135 doi: 10.1016/j.tifs.2019.12.013
|
92 |
Joana Fisch, Ana Carolina de Moura, Vanessa Feistauer, Luiza Steffens Reinhardt, Patrícia Molz, Ana Moira Morás, Dinara Jaqueline Moura, Priscila Oliveira de Souza, Elizandra Braganhol, Silvana Almeida, Renata Padilha Guedes, Alethéa Gatto Barschak, Márcia Giovenardi. Effects of different maternal diets on adipose tissue inflammation and liver tissue oxidative stress in dams and their female offspring. Molecular and Cellular Biochemistry 2024; 479(5): 1257 doi: 10.1007/s11010-023-04791-3
|
93 |
Ayane A. Rodrigues, Raíssa S. B. Andrade, Daniel F. P. Vasconcelos. Relationship between Experimental Diet in Rats and Nonalcoholic Hepatic Disease: Review of Literature. International Journal of Hepatology 2018; 2018: 1 doi: 10.1155/2018/9023027
|
94 |
James M Antonini, Vamsi Kodali, Mohammad Shoeb, Michael Kashon, Katherine A Roach, Gregory Boyce, Terence Meighan, Samuel Stone, Walter McKinney, Theresa Boots, Jenny R Roberts, Patti C Zeidler-Erdely, Aaron Erdely. Effect of a High-Fat Diet and Occupational Exposure in Different Rat Strains on Lung and Systemic Responses: Examination of the Exposome in an Animal Model. Toxicological Sciences 2020; 174(1): 100 doi: 10.1093/toxsci/kfz247
|
95 |
Masanori Tokoro, Koro Gotoh, Yoko Kudo, Yuka Hirashita, Masao Iwao, Mie Arakawa, Mizuki Endo, Junya Oribe, Takayuki Masaki, Koichi Honda, Tetsuya Kakuma, Masataka Seike, Kazunari Murakami, Hirotaka Shibata. α‐Tocopherol suppresses hepatic steatosis by increasing CPT‐1 expression in a mouse model of diet‐induced nonalcoholic fatty liver disease. Obesity Science & Practice 2021; 7(1): 91 doi: 10.1002/osp4.460
|
96 |
Xiaodong Zhai, Suyang Li, Tongsheng Wang, Jinbo Bai, Fengqing Xu, Wuxi Zhou. Dark Tea Wine Protects Against Metabolic Dysfunction-Associated Steatotic Liver Disease In Vivo Through Activating the Nrf2/HO-1 Antioxidant Signaling Pathway. Journal of Medicinal Food 2024; 27(10): 912 doi: 10.1089/jmf.2024.k.0064
|
97 |
Kareem M Abdelraheem, Nahla N Younis, Mohamed A Shaheen, Sahar E Elswefy, Sousou I Ali. Raspberry ketone improves non-alcoholic fatty liver disease induced in rats by modulating sphingosine kinase/sphingosine-1-phosphate and toll-like receptor 4 pathways. Journal of Pharmacy and Pharmacology 2023; 75(7): 985 doi: 10.1093/jpp/rgad044
|
98 |
Nur Abu Ahmad, Merav Raizman, Nathalie Weizmann, Brandi Wasek, Erland Arning, Teodoro Bottiglieri, Oren Tirosh, Aron M. Troen. Betaine attenuates pathology by stimulating lipid oxidation in liver and regulating phospholipid metabolism in brain of methionine‐choline–deficient rats. The FASEB Journal 2019; 33(8): 9334 doi: 10.1096/fj.201802683R
|
99 |
K. Gupta, Z. Song, H. Tang, E.L.S. Fong, I.C. Ng, H. Yu. Comprehensive Biomaterials II. 2017; : 491 doi: 10.1016/B978-0-12-803581-8.10163-8
|
100 |
Li Zhao, Zhen Cang, Honglin Sun, Xiaomin Nie, Ningjian Wang, Yingli Lu. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease. BMC Endocrine Disorders 2017; 17(1) doi: 10.1186/s12902-017-0165-7
|
101 |
Erenius Toppo, Naif Abdullah Al-Dhabi, Chinnakulandai Sankar, Sanmugapriya Nagul Kumar, Kanniappan Buvanesvaragurunathan, Santhanam Sylvester Darvin, Antony Stalin, Kedeke Balakrishna, Stanislaus Antony Ceasar, Perumal Pandikumar, Savarimuthu Ignacimuthu, Kuppusamy Sivasankaran, Paul Agastian. Hepatoprotective effect of selected isoandrographolide derivatives on steatotic HepG2 cells and High Fat Diet fed rats. European Journal of Pharmacology 2021; 899: 174056 doi: 10.1016/j.ejphar.2021.174056
|
102 |
Henrik H. Hansen, Gitte Hansen, Thomas Secher, Michael Feigh, Sanne S. Veidal, Keld Fosgerau, Jacob Jelsing, Niels Vrang. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. 2019; : 369 doi: 10.1007/978-3-030-11748-1_14
|
103 |
Bartosz Fotschki, Michał Sójka, Monika Kosmala, Jerzy Juśkiewicz. Prebiotics Together with Raspberry Polyphenolic Extract Mitigate the Development of Nonalcoholic Fatty Liver Diseases in Zucker Rats. Nutrients 2023; 15(14): 3115 doi: 10.3390/nu15143115
|
104 |
Anuradha Pandey, Priyank Raj, Santosh Kumar Goru, Almesh Kadakol, Vajir Malek, Nisha Sharma, Anil Bhanudas Gaikwad. Esculetin ameliorates hepatic fibrosis in high fat diet induced non-alcoholic fatty liver disease by regulation of FoxO1 mediated pathway. Pharmacological Reports 2017; 69(4): 666 doi: 10.1016/j.pharep.2017.02.005
|
105 |
Mahak Arora, Nikolina Kutinová Canová, Hassan Farghali. mTOR as an eligible molecular target for possible pharmacological treatment of nonalcoholic steatohepatitis. European Journal of Pharmacology 2022; 921: 174857 doi: 10.1016/j.ejphar.2022.174857
|
106 |
Xiang Liu, Zhi-Hong Xie, Chen-Yuan Liu, Ying Zhang. Effect of Chinese Herbal Monomer Hairy Calycosin on Nonalcoholic Fatty Liver Rats and its Mechanism. Combinatorial Chemistry & High Throughput Screening 2019; 22(3): 194 doi: 10.2174/1386207322666190411112814
|
107 |
Yu Matsumoto, Saya Fujita, Ayano Yamagishi, Tomomi Shirai, Yukie Maeda, Tsukasa Suzuki, Ken-ichi Kobayashi, Jun Inoue, Yuji Yamamoto. Brown Rice Inhibits Development of Nonalcoholic Fatty Liver Disease in Obese Zucker (fa/fa) Rats by Increasing Lipid Oxidation Via Activation of Retinoic Acid Synthesis. The Journal of Nutrition 2021; 151(9): 2705 doi: 10.1093/jn/nxab188
|
108 |
FX Himawan Haryanto Jong, Ari Gunawan, Mochamad Wirono Aman Santoso, Susilowati Anjani, Ni Wayan Tirthaningsih, Ahmad Basori. Effects of Sambiloto Ethanol Extract on Fatty Liver, SGOT/SGPT Levels and Lipid Profile of Wistar Strain White Rat (Rattus norvegicus) Exposed to High-Fat Diet. Folia Medica Indonesiana 2018; 54(2): 89 doi: 10.20473/fmi.v54i2.8856
|
109 |
Laura G. Di Pasqua, Clarissa Berardo, Vittoria Rizzo, Plinio Richelmi, Anna Cleta Croce, Mariapia Vairetti, Andrea Ferrigno. MCD diet-induced steatohepatitis is associated with alterations in asymmetric dimethylarginine (ADMA) and its transporters. Molecular and Cellular Biochemistry 2016; 419(1-2): 147 doi: 10.1007/s11010-016-2758-2
|
110 |
Hideo Ogiso, Kouichi Miura, Ryozo Nagai, Hitoshi Osaka, Kenichi Aizawa. Non-Targeted Metabolomics Reveal Apomorphine’s Therapeutic Effects and Lysophospholipid Alterations in Steatohepatitis. Antioxidants 2024; 13(11): 1293 doi: 10.3390/antiox13111293
|
111 |
Mojgan Mohammadifar, Mohsen Taghizadeh, Alireza Abed, Ali Soltani, Omidreza Tamtaji, Tahereh Khamechian, Alireza Hatami, Sayyed Alireza Talaei. Effect of Ziziphus jujuba Mill., Cichorium intybus L. and Silybum marianum (L.) Gaertn. Combination Extract on Non-alcoholic Fatty Liver Disease in Rats. Journal of Medicinal Plants 2020; 4(72): 133 doi: 10.29252/jmp.4.72.S12.133
|
112 |
Ting Zhai, Wei Xu, Yayun Liu, Kun Qian, Yanling Xiong, Yong Chen, Tullia Maraldi. Honokiol Alleviates Methionine-Choline Deficient Diet-Induced Hepatic Steatosis and Oxidative Stress in C57BL/6 Mice by Regulating CFLAR-JNK Pathway. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/2313641
|
113 |
Guglielmina Chimienti, Antonella Orlando, Francesco Russo, Benedetta D’Attoma, Manuela Aragno, Eleonora Aimaretti, Angela Maria Serena Lezza, Vito Pesce. The Mitochondrial Trigger in an Animal Model of Nonalcoholic Fatty Liver Disease. Genes 2021; 12(9): 1439 doi: 10.3390/genes12091439
|
114 |
Ariel Bier, Rawan Khasbab, Yael Haberman, Tzipi Braun, Rotem Hadar, Katya Sosnovski, Amnon Amir, Avshalom Leibowitz, Ehud Grossman. Antibiotic Treatment Does Not Ameliorate the Metabolic Changes in Rats Presenting Dysbiosis After Consuming a High Fructose Diet. Nutrients 2020; 12(1): 203 doi: 10.3390/nu12010203
|
115 |
Hassan Reda Hassan Elsayed, Mohammad El-Nablaway, Basma H. Othman, Asim Mohammed Abdalla, Eman Mohammad El Nashar, Mostafa Mohammed Abd-Elmonem, Randa El-Gamal. Can Dasatinib Ameliorate the Hepatic changes, Induced by Long Term Western Diet, in Mice?. Annals of Anatomy - Anatomischer Anzeiger 2021; 234: 151626 doi: 10.1016/j.aanat.2020.151626
|
116 |
Matthias Ocker. Challenges and opportunities in drug development for nonalcoholic steatohepatitis. European Journal of Pharmacology 2020; 870: 172913 doi: 10.1016/j.ejphar.2020.172913
|
117 |
Heba Fikry, Lobna A. Saleh, Doaa Ramadan Sadek, Hadwa Ali Abd Alkhalek. The possible protective effect of luteolin on cardiovascular and hepatic changes in metabolic syndrome rat model. Cell and Tissue Research 2024; doi: 10.1007/s00441-024-03927-1
|
118 |
Haru Yamamoto, Tatsuya Usui, Kazuaki Sasaki. Development of liver organoids from NASH model mice and their application to drug discovery. Folia Pharmacologica Japonica 2021; 156(5): 275 doi: 10.1254/fpj.21027
|
119 |
Xin Tong, Li Lin, Peng Hu, Rui Cao, Yang Zhang, Joshua Olick‐Gibson, Lihong V. Wang. Non‐Invasive 3D Photoacoustic Tomography of Angiographic Anatomy and Hemodynamics of Fatty Livers in Rats. Advanced Science 2023; 10(2) doi: 10.1002/advs.202205759
|
120 |
David Haldrup, Sara Heebøll, Karen Louise Thomsen, Kasper Jarlhelt Andersen, Michelle Meier, Frank Viborg Mortensen, Jens Randel Nyengaard, Stephen Hamilton-Dutoit, Henning Grønbæk. Preserved liver regeneration capacity after partial hepatectomy in rats with non-alcoholic steatohepatitis. World Journal of Hepatology 2018; 10(1): 8-21 doi: 10.4254/wjh.v10.i1.8
|
121 |
Hee Jin Jeong, Song Hee Lee, Hee Eun Kang. Changes in digoxin pharmacokinetics associated with hepatic P‐glycoprotein upregulation in rats with non‐alcoholic fatty liver disease. Fundamental & Clinical Pharmacology 2021; 35(6): 1100 doi: 10.1111/fcp.12687
|
122 |
Mahmoud Hussein Hassan Ali, Basim Anwar Shehata Messiha, Hekma Abdel-Tawab Abdel-Latif. Protective effect of ursodeoxycholic acid, resveratrol, andN-acetylcysteine on nonalcoholic fatty liver disease in rats. Pharmaceutical Biology 2015; : 1 doi: 10.3109/13880209.2015.1060247
|
123 |
Alfredo Fernández-Quintela, Marcela González, Leixuri Aguirre, Iñaki Milton-Laskibar, Asier Léniz, Maria P. Portillo. The Liver. 2018; : 199 doi: 10.1016/B978-0-12-803951-9.00017-3
|
124 |
Sheila Cristina L. Sanches, Leandra Naira Z. Ramalho, Marlei Josiele Augusto, Deisy Mara da Silva, Fernando Silva Ramalho. Nonalcoholic Steatohepatitis: A Search for Factual Animal Models. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/574832
|
125 |
WEIHAN ZHAO, LIJUAN LIU, YUNLIANG WANG, TANGYOU MAO, JUNXIANG LI. Effects of a combination of puerarin, baicalin and berberine on the expression of proliferator-activated receptor-γ and insulin receptor in a rat model of nonalcoholic fatty liver disease. Experimental and Therapeutic Medicine 2016; 11(1): 183 doi: 10.3892/etm.2015.2846
|
126 |
Rafael Sales, Priscylla Medeiros, Flavia Spreafico, Patrícia De Velasco, Fernanda Gonçalves, Roberto Martín-Hernández, Diana Mantilla-Escalante, Judit Gil-Zamorano, Wilza Peres, Sergio De Souza, Alberto Dávalos, Maria Tavares do Carmo. Olive Oil, Palm Oil, and Hybrid Palm Oil Distinctly Modulate Liver Transcriptome and Induce NAFLD in Mice Fed a High-Fat Diet. International Journal of Molecular Sciences 2018; 20(1): 8 doi: 10.3390/ijms20010008
|
127 |
Chandrashekhar Singh, Chandra Prakash, Pallavi Mishra, Kavindra Nath Tiwari, Sunil Kumar Mishra, Raghunath Shahaji More, Vijay Kumar, Jasmeet Singh. Hepatoprotective efficacy of Premna integrifolia L. leaves against aflatoxin B1-induced toxicity in mice. Toxicon 2019; 166: 88 doi: 10.1016/j.toxicon.2019.05.014
|
128 |
Nikolaos Sikalias, Theodore Karatzas, Konstantinos Alexiou, Lamprini Mountzalia, Maria Demonakou, Ioannis D. Kostakis, Argyro Zacharioudaki, Apostolos Papalois, Gregory Kouraklis. Intermittent Ischemic Preconditioning Protects Against Hepatic Ischemia-Reperfusion Injury and Extensive Hepatectomy in Steatotic Rat Liver. Journal of Investigative Surgery 2018; 31(5): 366 doi: 10.1080/08941939.2017.1334844
|
129 |
Kyohei Yasuno, Kazuyoshi Kumagai, Takuma Iguchi, Yoshimi Tsuchiya, Kiyonori Kai, Kazuhiko Mori. DS-7250, a Diacylglycerol Acyltransferase 1 Inhibitor, Enhances Hepatic Steatosis in Zucker Fatty Rats via Upregulation of Fatty Acid Synthesis. Toxicologic Pathology 2018; 46(3): 302 doi: 10.1177/0192623318765909
|
130 |
T. SAITO, M. MURAMATSU, Y. ISHII, Y. SAIGO, T. KONUMA, Y. TORINIWA, K. MIYAJIMA, T. OHTA. Pathophysiological Analysis of the Progression of Hepatic Lesions in STAM Mice. Physiological Research 2017; : 791 doi: 10.33549/physiolres.933592
|
131 |
Hongmei Mao, Wenjun Wang, Xuesong Xiang, Yan Li, Jinpeng Zhao, Yin Huang, Shuangshuang Di, Qin Zhuo, Honggang Nie. Analysis of Metabolite Distribution in Rat Liver of High-Fat Model by Mass Spectrometry Imaging. Metabolites 2023; 13(3): 411 doi: 10.3390/metabo13030411
|
132 |
Syifa Mustika, Dewi Santosaningsih, Dian Handayani, Achmad Rudijanto. Impact of multiple different high-fat diets on metabolism, inflammatory markers, dysbiosis, and liver histology: study on NASH rat model induced diet. F1000Research 2023; 12: 180 doi: 10.12688/f1000research.129645.2
|
133 |
Xin Guo, Jiaqi Liu, Liuping You, Gang Li, Yuenan Huang, Yunlong Li. Association Between Adiponectin Polymorphisms and the Risk of Colorectal Cancer. Genetic Testing and Molecular Biomarkers 2015; 19(1): 9 doi: 10.1089/gtmb.2014.0238
|
134 |
Naruemon Klaikeaw, Jutamas Wongphoom, Duangporn Werawatganon, Maneerat Chayanupatkul, Prasong Siriviriyakul. Anti-inflammatory and anti-oxidant effects of aloe vera in rats with non-alcoholic steatohepatitis. World Journal of Hepatology 2020; 12(7): 364 doi: 10.4254/wjh.v12.i7.364
|
135 |
Eduardo E. Vargas-Pozada, Erika Ramos-Tovar, Juan D. Rodriguez-Callejas, Irina Cardoso-Lezama, Silvia Galindo-Gómez, Daniel Talamás-Lara, Verónica Rocío Vásquez-Garzón, Jaime Arellanes-Robledo, Víctor Tsutsumi, Saúl Villa-Treviño, Pablo Muriel. Caffeine Inhibits NLRP3 Inflammasome Activation by Downregulating TLR4/MAPK/NF-κB Signaling Pathway in an Experimental NASH Model. International Journal of Molecular Sciences 2022; 23(17): 9954 doi: 10.3390/ijms23179954
|
136 |
V. I. Pivtorak, B. V. Sydorenko, V. M. Monastyrskyi, K. V. Pivtorak, M. P. Bulko. EFFICACY OF AN EXPERIMENTAL MODEL OF NON-ALCOHOLIC FATTY LIVER DISEASE BASED ON A HIGH-FAT DIET WITH CHOLESTEROL. World of Medicine and Biology 2022; 18(80): 222 doi: 10.26724/2079-8334-2022-2-80-222-226
|
137 |
Feryal Savari, Seyyed Ali Mard, Mohammad Badavi, Anahita Rezaie, Mohammad Kazem Gharib-Naseri. A new method to induce nonalcoholic steatohepatitis (NASH) in mice. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1041-x
|
138 |
Quiana C. Wilkerson-Vidal, Madushika M. Wimalarathne, Emily C. Hunt, Luis Mercado, Moses Adaji David, Christopher R. Apperson, Alan Smiley, Sharifa Tahirah Love-Rutledge, Bernhard W. G. Vogler. Male LEW.1WR1 Rats Develop Metabolic Dysfunction, Steatohepatitis, and Liver Damage. Endocrines 2024; 5(2): 166 doi: 10.3390/endocrines5020012
|
139 |
Linqiang Zhang, Xiaoyun Wu, Shasha Liao, Yunhai Li, Zhiguo Zhang, Qing Chang, Ruyue Xiao, Bin Liang. Tree shrew (Tupaia belangeri chinensis), a novel non-obese animal model of non-alcoholic fatty liver disease. Biology Open 2016; 5(10): 1545 doi: 10.1242/bio.020875
|
140 |
Pierre-Antoine Soret, Julie Magusto, Chantal Housset, Jérémie Gautheron. In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal. Journal of Clinical Medicine 2020; 10(1): 36 doi: 10.3390/jcm10010036
|